Connect with us


1,502 Dead, 95,901 Discharged As Nigeria Records 1,633 Fresh Covid-19 Cases



COVID-19 cases surpassed the 120,000 mark in Nigeria on Saturday after the Nigerian Centre for Disease Control, NCDC reported 1,633 new infections.

According to the NCDC, total confirmed COVID-19 cases in Nigeria now stand at 120,602, with 95,901 recoveries recorded so far.

Five deaths were reported on Saturday, taking the overall national death rate to 1,502.

However, COVID-19 cases fell sharply in Nigeria on Saturday, with 1,633 new infections reported.

This represents a sharp drop from the all-time high 2,213 cases posted on Friday.

Lagos and Plateau States posted the highest cases, but infections drop in Lagos and rose in Plateau.

Lagos reported 498 fresh cases, representing a drop from the 831 cases posted the previous day while Plateau recorded 214 cases, a rise from the 127 cases raked in on Friday.

The Federal Capital Territory, FCT, Abuja ramp up 179 new cases, a drop from the 235 cases posted the previous day.

Others are: Rivers-99, Kaduna-98, Edo-87, Anambra-86, Akwa Ibom-50, Osun-47, Kano-40, Oyo-40, Kwara-39, Ebonyi-28, Niger-28, Taraba-28, Ogun-27, Ondo-21, Ekiti-12, Katsina-7, Borno-6 and Delta-2.

New cases were reported in 20 States and the FCT on Saturday.

See figures below

Akwa Ibom-50

120,602 confirmed
95,901 discharged
1,502 deaths

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *


Pfizer Identifies Counterfeit Covid-19 Vaccines In Mexico, Poland



US pharmaceutical company Pfizer has identified fake doses of its vaccine against Covid-19 in Mexico and Poland, Sputnik quoted The Wall Street Journal report.

In Mexico, some 80 people got fraudulent vaccines at a clinic for about US$1,000 (RM4,110) per dose. The doses also had fake labels.

In Poland, fake doses of the Covid-19 vaccine are likely to have been an anti-wrinkle medicine. The Polish authorities said that no one had received the fake vaccines.

The World Health Organization (WHO) declared the Covid-19 outbreak a pandemic on March 11, 2020. To date, more than 143.48 million people have been infected with the coronavirus worldwide, with over 3.05 million fatalities, according to Johns Hopkins University.

Continue Reading


BREAKING: AstraZeneca Covid-19 Vaccine Can Cause Unusual Blood Clot – EMA Affirms



The safety committee of the European Medicines Agency (EMA) has found that the Oxford-AstraZeneca Covid-19 vaccine can cause unusual blood clots with low blood platelets, but stresses the overall benefits of the vaccine in preventing coronavirus outweigh the risks of side effects.

“EMA is reminding healthcare professionals and people receiving the vaccine to remain aware of the possibility of very rare cases of blood clots combined with low levels of blood platelets occurring within 2 weeks of vaccination,” the agency said in a statement Wednesday.

“So far, most of the cases reported have occurred in women under 60 years of age within 2 weeks of vaccination. Based on the currently available evidence, specific risk factors have not been confirmed.”

Continue Reading


No Reason To Stop Using AstraZeneca COVID-19 Vaccine – WHO



The World Health Organization said Friday there was no reason to stop using AstraZeneca’s Covid-19 vaccine after several European countries suspended the roll-out over blood clot fears.

The WHO said its vaccines advisory committee was currently looking at safety data and stressed that no causal link had been established between the vaccine and clotting.

Denmark, Norway, Iceland, Italy and Romania postponed or limited the rollout of AstraZeneca vaccines after isolated reports of recipients developing blood clots.

“AstraZeneca is an excellent vaccine, as are the other vaccines that are being used,” WHO spokeswoman Margaret Harris told reporters at a briefing in Geneva.

“We’ve reviewed the data on deaths. There has been no death, to date, proven to have be caused by vaccination,” she said.

“Yes, we should continue using the AstraZeneca vaccine,” she added, stressing though that “any safety signal must be investigated.”

“We must always ensure that we look for any safety signals when we roll out vaccines, and we must review them,” she said.

“But there is no indication to not use it.”

Continue Reading